Recent Patents on Biotechnology
Title:Editorial [Welcome to our Recent Patents on Biotechnology Special Edition on Skeletal Muscle Diseases!]
Volume: 6 Issue: 3
Author(s): Marco Brotto
Affiliation:
Export Options
About this article
Cite this article as:
Brotto Marco, Editorial [Welcome to our Recent Patents on Biotechnology Special Edition on Skeletal Muscle Diseases!], Recent Patents on Biotechnology 2012; 6 (3) . https://dx.doi.org/10.2174/1872208311206030155
DOI https://dx.doi.org/10.2174/1872208311206030155 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design Placebo Effects in Therapeutic Outcomes
Current Clinical Pharmacology Treatment of Chronic Hepatitis B: From Research to Clinical Practice Via the Consensus Conferences
Current Pharmaceutical Design Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands
Current Pharmaceutical Design Targeting Neuropathic Pain: Pathobiology, Current Treatment and Peptidomimetics as a New Therapeutic Opportunity
Current Medicinal Chemistry Reproduction in Couples with Chronic Viral Infections
Current Women`s Health Reviews Mimetics of the Peptide β-Strand
Mini-Reviews in Medicinal Chemistry The Role of Tomatine Adjuvant in Antigen Delivery for Cross- Presentation
Current Drug Delivery Chemical Inhibition of Matrix Metalloproteinases for Periodontal Treatment
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Gene Therapy Strategies for Glaucomatous Neurodegeneration
Current Gene Therapy Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy
Current Cancer Drug Targets Anti-Diabetic Compounds and their Patent Information: An Update
Recent Patents on Inflammation & Allergy Drug Discovery Attenuation of ERK/RSK2-Driven NFκB Gene Expression and Cancer Cell Proliferation by Kurarinone, a Lavandulyl Flavanone Isolated from Sophora flavescens Ait. Roots
Endocrine, Metabolic & Immune Disorders - Drug Targets Augmentation of Citalopram with Aspirin for Treating Major Depressive Disorder, a Double Blind Randomized Placebo Controlled Clinical Trial
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Crosstalk between Inflammation and Coagulation: The Lessons of Sepsis
Current Vascular Pharmacology Chlorophytum borivilianum: A White Gold for Biopharmaceuticals and Neutraceuticals
Current Pharmaceutical Biotechnology Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
Current Molecular Medicine The Akt-mTOR Pathway in Down’s Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits
CNS & Neurological Disorders - Drug Targets Intravesical Therapy of Superficial Bladder Cancer
Current Pharmaceutical Design